ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Heron Therapeautics Inc

Heron Therapeautics Inc (HRTX)

1.78
0.04
(2.30%)
Closed November 02 4:00PM
1.74
-0.04
(-2.25%)
After Hours: 6:59PM

Heron Therapeautics Inc Financial Summary

The current HRTX market cap is 263.9M. The company's latest EPS is USD -0.7290 and P/E is -2.46.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 31.76M31.43M34.23M34.67M36.02M
Operating Income -42.4M-24.93M-10.22M-4.8M-6.45M
Net Income -42.06M-25.01M-10.72M-3.16M-9.24M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 145.97M88.64M86.35M107.67M127.04M
Operating Income -210.69M-228.16M-217.83M-177.55M-110.62M
Net Income -204.75M-227.28M-220.68M-184.91M-110.56M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 201.22M229.2M222.51M217.89M218.14M
Total Liabilities 240.51M256.99M256.48M251.65M256.08M
Total Equity -39.28M-27.79M-33.97M-33.77M-37.94M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 512.78M353.56M305.71M250.95M222.51M
Total Liabilities 108.95M117.06M228.14M237.38M256.48M
Total Equity 403.84M236.49M77.57M13.57M-33.97M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -52.07M-61.24M-58.79M-9.52M-14.12M
Investing 50.05M26.83M18M1.28M3.33M
Financing 111k53.91M54.11M11k503k
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -124.58M-184.82M-203.35M-146.91M-58.79M
Investing -21.78M208.96M32.73M-3.32M18M
Financing 186.43M9.11M156.03M75.06M54.11M
Market Cap 263.9M
Price to Earnings Ratio -2.46
Price to Sales Ratio 2.14
Price to Cash Ratio 9.47
Price to Book Ratio -7.99
Dividend Yield -

Share Statistics

Shares Outstanding 151.67M
Average Volume (1 week) 1.66M
Average Volume (1 Month) 1.33M
52 Week Change 167.69%
52 Week High 3.90
52 Week Low 0.50
Spread (Intraday) 0.05 (2.81%)

Company Info

Company Name Heron Therapeautics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.herontx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock